시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 바이오마커 시장 규모, 점유율, 성장 분석 : 제품별, 유형별, 조사 분야별, 기술별, 적응 질환별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Biomarkers Market Size, Share, and Growth Analysis, By Product, By Type, By Research Area, By Technology, By Disease Indication, By Application, By End User, By Region - Industry Forecast 2025-2032
상품코드 : 1701044
리서치사 : SkyQuest
발행일 : 2025년 04월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,828,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 9,158,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,487,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

바이오마커 시장 규모는 2023년 582억 달러로 평가되었고, 예측 기간(2025-2032년) 동안 13.5%의 연평균 복합 성장률(CAGR)로 성장하여 2024년 660억 6,000만 달러에서 2032년에는 1,819억 2,000만 달러로 성장할 것으로 예측됩니다.

바이오마커 시장은 만성질환 증가, 기술 발전, 개인 맞춤형 의료에 대한 수요 증가로 인해 강력한 성장세를 보이고 있습니다. 전 세계적으로 환자 수가 증가함에 따라 바이오마커를 통한 효과적인 조기 발견, 모니터링 및 진단에 대한 필요성이 증가하고 있습니다. 단백질체학, 유전체, 대사체학 기술의 혁신은 새로운 바이오마커의 발견을 촉진하고 시장 확대를 더욱 촉진하고 있습니다. 그러나 바이오마커의 개발 및 검증에 따른 높은 비용과 바이오마커의 장점에 대한 일반 대중의 인식이 제한적이라는 점은 성장에 걸림돌이 될 수 있습니다. 이러한 장애물에도 불구하고, 맞춤형 의료와 지속적인 기술 발전의 형태로 기회는 풍부하며, 바이오마커 시장은 개발 및 투자 기회가 무르익어가고 있습니다.

목차

서론

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

바이오마커 시장 규모 : 제품 및 서비스별

바이오마커 시장 규모 : 유형별

바이오마커 시장 규모 : 조사 분야별

바이오마커 시장 규모 : 기술별

바이오마커 시장 규모 : 적응 질환별

바이오마커 시장 규모 : 용도별

바이오마커 시장 규모 : 최종사용자별

바이오마커 시장 규모

경쟁 정보

주요 기업 개요

결론과 제안

LSH
영문 목차

영문목차

Biomarkers Market size was valued at USD 58.2 billion in 2023 and is poised to grow from USD 66.06 billion in 2024 to USD 181.92 billion by 2032, growing at a CAGR of 13.5% during the forecast period (2025-2032).

The biomarkers market is experiencing robust growth, primarily fueled by the increasing prevalence of chronic diseases, advancements in technology, and a growing demand for personalized medicine. As global patient numbers rise, the need for effective early detection, monitoring, and diagnosis through biomarkers is intensifying. Innovations in proteomic, genomic, and metabolomics technologies are facilitating the discovery of new biomarkers, further propelling market expansion. However, challenges such as high costs associated with biomarker development and validation, as well as limited public awareness regarding their benefits, may hinder growth. Despite these obstacles, opportunities abound in the form of tailored medicine and continued technological advancements, making the biomarkers market ripe for development and investment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biomarkers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biomarkers Market Segments Analysis

Global Biomarkers Market is segmented by Product, Type, Research Area, Technology, Disease Indication, Application, End User and region. Based on Product, the market is segmented into Consumables, Services and Software. Based on Type, the market is segmented into Safety Biomarkers, Efficacy Biomarkers and Validation Biomarkers. Based on Research Area, the market is segmented into Genomics, Proteomics, Metabolomics and Other Research Areas. Based on Technology, the market is segmented into Immunoassays, NGS, PCR, Mass Spectrometry,Chromatographyand Other Technologies. Based on Disease Indication, the market is segmented into Cancer, Infectious Diseases, Immunological Disorders, Neurological Disorders, Cardiovascular Disorders and Other Disease Indications. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development, Personalized Medicine, Clinical Research and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biomarkers Market

The demand for biomarkers is rapidly increasing as healthcare shifts towards more personalized treatment approaches that consider the unique needs and genetic profiles of patients. This trend underscores the pivotal role of biomarkers in improving therapeutic outcomes. In recent years, the growth has been propelled by advanced research initiatives in biotechnology and molecular biology, which are facilitating the identification and application of novel biomarkers across various medical fields. As a result, there is a burgeoning interest in leveraging these biological indicators to tailor medical treatments, ultimately enhancing patient care and driving further innovation in the biomarkers market.

Restraints in the Biomarkers Market

The biomarkers market faces several significant challenges that could hinder its growth. Variability in biomarker testing methodologies and a lack of standardized practices across platforms can lead to inconsistent results, deterring widespread adoption. Additionally, the validation process for biomarkers associated with specific conditions and diseases often proves to be complex and time-consuming, further impeding progress. These hurdles not only slow the overall development of new biomarker technologies but also potentially restrict the market's expansion, as stakeholders may be hesitant to invest in uncertain outcomes or prolonged timelines for validation efforts.

Market Trends of the Biomarkers Market

The biomarker market is witnessing a significant trend towards the increased utilization of vitality biomarkers, which empower healthcare providers to assess patients' health proactively, even before symptoms manifest. This shift towards early intervention is crucial in averting the progression of various health conditions, thus enhancing patient outcomes. The integration of IoT devices and wearables into healthcare is further amplifying this trend, as these technologies enable continuous monitoring of vital health metrics in real-time. The resulting rich datasets not only facilitate personalized treatment plans but also bolster the quality of diagnostics, paving the way for innovative solutions in preventive medicine and chronic disease management.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Biomarkers Market Size by Product & Service & CAGR (2025-2032)

Global Biomarkers Market Size by Type & CAGR (2025-2032)

Global Biomarkers Market Size by Research Area & CAGR (2025-2032)

Global Biomarkers Market Size by Technology & CAGR (2025-2032)

Global Biomarkers Market Size by Disease Indication & CAGR (2025-2032)

Global Biomarkers Market Size by Application & CAGR (2025-2032)

Global Biomarkers Market Size by End User & CAGR (2025-2032)

Global Biomarkers Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기